v3.26.1
Other Shareholders’ Equity (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Dec. 02, 2025
Oct. 01, 2025
Jun. 30, 2024
Nov. 30, 2024
Jan. 31, 2022
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2025
Jun. 17, 2022
Jun. 08, 2018
Apr. 10, 2009
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Selling expense           $ 147,000 $ 141,000            
Impairment charge $ 1,318,000                        
Reverse stock split   1-for-10                      
Stock price volatility, minimum             240.00%            
Stock price volatility, maximum             243.00%            
Risk free interest rate             15.16%            
Expected life             3 years            
Dividend yield             0.00%            
Share based compensation expense           25,000 $ 160,000            
Unrecognized compensation expense           $ 133,000 $ 155,000            
Stock based plan, vesting term           4 years              
Stock based plan, vesting schedule           3 years              
Stock Incentive Plan 2009 [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Shares authorized for issuance                         510,000
Stock Incentive Plan 2018 [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Shares authorized for issuance                     500,000 300,000  
Restricted Stock [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of restricted shares vested         16,875                
Number of shares vested                 8,000        
Performance Shares [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Restricted stock granted           19,800              
Chief Executive Officer [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of restricted shares vested             2,000            
Chief Executive Officer [Member] | Restricted Stock [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Restricted stock granted       25,000 25,000     2,000          
Number of restricted shares vested       2,500 2,500   4,000            
Remaining shares       22,500 22,500                
Chief Executive Officer [Member] | Restricted Stock [Member] | Trailing Twelve Month EBITDA Equals or Exceeds 0.7 Million [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of restricted shares vested       5,625                  
Restricted shares vested, description       vest when the Company’s trailing-twelve-month EBITDA equals or exceeds $0.7 million at any time on or after January 1, 2026.                  
Chief Executive Officer [Member] | Restricted Stock [Member] | Common Shares Trade At or Above 3 Share for Ten or More Consecutive Trading Days [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of restricted shares vested       5,625                  
Restricted shares vested, description       vest in the event the Company’s common shares trade at or above $30/share for ten or more consecutive trading days.                  
Chief Executive Officer [Member] | Restricted Stock [Member] | Ms. Schwan Remains an Employee of the Company [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of restricted shares vested       5,625                  
Restricted shares vested, description       vest if Ms. Schwan remains an employee of the Company as of January 1, 2027.                  
Chief Executive Officer [Member] | Restricted Stock [Member] | Refinance its Credit Facility [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of restricted shares vested       5,625                  
Mr. Cesarios [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Restricted stock granted             5,625            
Mr. Cesarios [Member] | Restricted Stock [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of restricted shares vested         19,375                
Chief Operating Officer [Member] | Restricted Stock [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Number of shares granted                 10,000        
Number of shares vested                 2,000        
Series E and F Preferred Stock [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Warrants to purchase shares                   55,600      
Exercise price of warrants                   $ 15.2      
Percentage of variable price on VWAP                   90.00%      
Common Stock [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Transferred shares of common stock 175,000           500,000            
Reduction amount $ 874,000                        
Asset Purchase Agreement [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Transferred shares of common stock     500,000                    
Fair value of common stock     $ 6,250,000                    
Selling expense     2,200,000                    
Asset Purchase Agreement [Member] | Machinery and Equipment [Member]                          
Accumulated Other Comprehensive Income (Loss) [Line Items]                          
Fair value of machinery and equipment     $ 4,050,000.00